Loading…
Use of clozapine in tardive dystonia
1. 1. This open clinical trial (N = 7) measured the course of severe tardive dystonia in chronic psychiatric patients after discontinuation of neuroleptics and subsequent use of clozapine. 2. 2. The dystonia was regularly assessed using the Fahn-Marsden Rating Scale. The eventual concomitant tardive...
Saved in:
Published in: | Progress in neuro-psychopharmacology & biological psychiatry 1996-02, Vol.20 (2), p.263-274 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 1.
1. This open clinical trial (N = 7) measured the course of severe tardive dystonia in chronic psychiatric patients after discontinuation of neuroleptics and subsequent use of clozapine.
2.
2. The dystonia was regularly assessed using the Fahn-Marsden Rating Scale. The eventual concomitant tardive dyskinesia was assessed using the Abnormal Involuntary Movement Scale. The mean follow up was 103 weeks.
3.
3. The results for the tardive dystonia: four patients recovered totally, two unproved considerably and one did not recover.
4.
4. The results for the concomitant tardive dyskinesia: five of the seven patients had also dyskinesia, one patient had a total, two a partly remission, one had a very fluctuating course, and one patient worsened. Another patient developed dyskinesia.
5.
5. It is suggested to consider clozapine for patients with tardive dystonia who have to continue antipsychotic treatment. |
---|---|
ISSN: | 0278-5846 1878-4216 |
DOI: | 10.1016/0278-5846(95)00309-6 |